Many modern clinical chemistry analysers allow direct sampling from primary blood collection tubes to simplify specimen preparation. These tubes usually contain a barrier to separate serum from cells, thus reducing interference from cellular metabolites. However, an absence of anticoagulant and glass construction makes these tubes unsuitable for some laboratories. In our laboratory we use plasma rather than serum for routine assays performed on our Hitachi 717 random access analyser (Hitachi Ltd, Tokyo, Japan) to avoid delays while specimens clot. Blood is collected in conventional plastic tubes containing lithium heparin and the plasma separated using plastic Pasteur pipettes. To further improve the efficiency of specimen handling we required a plastic blood tube containing lithium heparin and an effective barrier gel, thus allowing sampling and storage in the one tube.
The Greiner Vacuette blood tube (Cat. No. 455084) was assessed as a tube meeting these criteria, and special attention was given to analytes susceptible to haemolysis when the tube was used to store plasma above the separator gel over a period of 1 week.
MATERIALS AND METHODS
Blood specimens were collected from 10 Red Cross donors into 10 mL Johns Products and Greiner blood tubes each day for 4 days. Johns Products' polypropylene blood tubes (Cat. No. 020156), which are currently used for blood collection in our hospital and contain lithium heparin (15 UImL), were used as control tubes. Blood tubes were received in our laboratory within 2 h of collection, after which they were centrifuged for 10min at 3000g. Plasma in the lithium heparin tubes was transferred to sample cups suitable for use on the Hitachi 717. Greiner tubes and separated plasma were both stored at 4°C. Sample cups and the Greiner tubes were placed on the Hitachi sample tray in alternate positions. Each sample was analysed on the day of arrival for the following 18 analytes: sodium, potassium, chloride, bicarbonate, urea, creatinine, total protein, albumin, calcium, phosphate, alkaline phosphatase (ALP), bilirubin, urate, creatine kinase (CK), lactate dehydrogenase (LD), alanine transferase (ALT), aspartate transferase (AST), y-glutamyl transferase (GGT). Each set of 10 paired tubes was reanalysed both 1 day and 7 days after the original collection date in order to assess the effect of storage of plasma above the gel layer in the Greiner tubes, relative to the separated plasma, over this period.
RESULTS
The results shown in Table I for potassium, phosphate, LD and AST demonstrate a positive bias for samples collected in Greiner tubes compared to control tubes. The t-values indicate the observed difference in mean results is statistically significant, apart from AST on day 1. After storage at 4°C for 7 days, the levels of these four analytes in plasma from the Greiner tubes increase markedly in comparison to those measured using plasma from conventional blood tubes. LD is the analyte most affected by the Greiner tubes, with a positive bias of 15 U/L on day 1 increasing to a bias of 124 U/L by day 8. The other 14 analytes measured did not show this trend.
DISCUSSION
This evaluation reveals that despite the potential advantage of the Greiner tubes for primary sampling, they do not appear suitable for the analysis ofLD on the day of collection and for potassium, phosphate, AST and LD on subsequent days. These analytes are present in significant concentrations in red blood cells and thus their levels in plasma may be affected to varying degrees by haemolysis. Lactate dehydrogenase is an extremely sensitive indicator of haemolysis and the large discrepancy between values obtained for the lithium heparin control tubes and Greiner tubes suggest that a substantial improvement in the reliability of the barrier layer is required. The increase in results with time suggests that the barrier layer is ineffective in preventing leakage of analytes into the plasma layer rather than directly causing haemolysis. To improve safety, we would also recommend that the 'push-on' cap should be replaced with a screw cap.
